Tech Company Financing Transactions
Revero Funding Round
Revero secured a $5 million Seed venture capital round on 11/8/2022. Backers included Andreessen Horowitz, CapitalX and Goodwater Capital.
Transaction Overview
Company Name
Announced On
11/8/2022
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to expand its platform to provide full-scope medical treatment across the US in all 50 states. In the future, they will also extend the platform to address a broader range of metabolic conditions such as type-2 diabetes, heart disease, and mental health issues, including anxiety and depression.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
3031 Steiner St 2
San Francisco, CA 94123
USA
San Francisco, CA 94123
USA
Phone
Undisclosed
Website
Email Address
Overview
Revero is aiming to reverse autoimmune and other chronic diseases by addressing the root causes. Our digital clinic integrates nutritional therapy and clinical expertise with machine learning and digital tools to deliver data-driven continuous remote care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Masha Rostami
Co-Founder
Shawn Baker
Browse more venture capital transactions:
Prev: 11/8/2022: YonaLink venture capital transaction
Next: 11/8/2022: Sarbacane venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs